Hap Trading, LLC Abb Vie Inc. Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $13.4 Million - $15.6 Million	86,300 New	86,300 $242 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $137,600 - $154,970	-1,000 Reduced 6.94%	13,400 $65.1 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $2.06 Million - $2.38 Million	-15,400 Reduced 51.68%	14,400 $2.15 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $1.48 Million - $1.85 Million	11,200 Added 60.22%	29,800 $4.01 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.94 Million - $2.23 Million	-13,400 Reduced 41.88%	18,600 $105,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $248,958 - $298,566	1,800 Added 5.96%	32,000 $578,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $12.3 Million - $14.2 Million	-92,000 Reduced 75.29%	30,200 $240,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $10 Million - $12.7 Million	72,700 Added 146.87%	122,200 $983,000
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $6.37 Million - $7.91 Million	-48,288 Reduced 49.38%	49,500 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $29.3 Million - $37.1 Million	-273,100 Reduced 73.63%	97,788 $1.27 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $34.9 Million - $39.7 Million	328,328 Added 771.45%	370,888 $236,000
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $1.53 Million - $1.7 Million	14,500 Added 51.67%	42,560 $231,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $4.34 Million - $4.78 Million	-42,430 Reduced 60.19%	28,060 $126,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $296,686 - $400,557	-3,686 Reduced 4.97%	70,490 $696,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1.07 Million - $1.25 Million	-12,440 Reduced 14.36%	74,176 $234,000
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $1.85 Million - $2.47 Million	-25,184 Reduced 22.53%	86,616 $913,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $1.48 Million - $2.24 Million	22,900 Added 25.76%	111,800 $214,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $3.53 Million - $4.42 Million	49,000 Added 122.81%	88,900 $231,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $428,264 - $514,896	6,800 Added 20.54%	39,900 $208,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $755,550 - $965,770	11,500 Added 53.24%	33,100 $47,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $578,550 - $680,925	7,500 Added 53.19%	21,600 $25,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $15,569 - $19,202	200 Added 1.44%	14,100 $48,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $3.49 Million - $3.88 Million	-39,300 Reduced 73.87%	13,900 $40,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $4.39 Million - $5.19 Million	-48,900 Reduced 47.89%	53,200 $39,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $32.7 Million - $43.7 Million	-355,000 Reduced 77.66%	102,100 $111,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $29.9 Million - $32.8 Million	333,800 Added 270.72%	457,100 $112,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $8.61 Million - $11 Million	123,300	123,300 $701,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account